Melanoma targeting with DOTA-alpha-melanocyte-stimulating hormone analogs: structural parameters affecting tumor uptake and kidney uptake.

MLA

Froidevaux, Sylvie, et al. “Melanoma Targeting with DOTA-Alpha-Melanocyte-Stimulating Hormone Analogs: Structural Parameters Affecting Tumor Uptake and Kidney Uptake.” Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, vol. 46, no. 5, May 2005, pp. 887–95. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=15872364&authtype=sso&custid=ns315887.

APA

Froidevaux, S., Calame-Christe, M., Tanner, H., & Eberle, A. N. (2005). Melanoma targeting with DOTA-alpha-melanocyte-stimulating hormone analogs: structural parameters affecting tumor uptake and kidney uptake. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, 46(5), 887–895.

Chicago

Froidevaux, Sylvie, Martine Calame-Christe, Heidi Tanner, and Alex N Eberle. 2005. “Melanoma Targeting with DOTA-Alpha-Melanocyte-Stimulating Hormone Analogs: Structural Parameters Affecting Tumor Uptake and Kidney Uptake.” Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine 46 (5): 887–95. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=15872364&authtype=sso&custid=ns315887.